Global Medical REIT Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.88, with a low estimate of 10 and a high estimate of 11.75. The average target predicts an increase of 25.93% from the current stock price of 8.64.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$10.88	$11.75	$11.75
Change	+15.74%	+25.93%	+36.00%	+36.00%

* Price targets were last updated on Oct 18, 2024.

Analyst Ratings

The average analyst rating for GMRE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kai Klose Berenberg	Berenberg	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+36.00%	Oct 18, 2024
Bryan Maher B. Riley Securities	B. Riley Securities	Strong Buy Maintains $11 → $10	Strong Buy	Maintains	$11 → $10	+15.74%	May 13, 2024
Bryan Maher B. Riley Securities	B. Riley Securities	Strong Buy Maintains $12 → $11	Strong Buy	Maintains	$12 → $11	+27.31%	May 8, 2023
Bryan Maher B. Riley Securities	B. Riley Securities	Strong Buy Maintains $14 → $12	Strong Buy	Maintains	$14 → $12	+38.89%	Mar 6, 2023
Amanda Sweitzer Baird	Baird	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Oct 10, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

141.91M

Revenue Next Year

148.66M

from 141.91M

4.76%

from 141.91M

EPS This Year

n/a

from 0.23

EPS Next Year

0.08

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	141.91M	148.66M	154.16M
Revenue Growth	32.96%	32.53%	23.69%	18.41%	2.74%	-	4.76%	3.70%
EPS	0.10	-0.17	0.19	0.20	0.23	-	0.08	0.07
EPS Growth	-71.13%	-	-	4.57%	10.89%	-	-	-8.70%
Forward PE	-	-	-	-	-	-	110.48	121.01
No. Analysts	-	-	-	-	-	6	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	146.9M	161.2M	168.8M
Avg	141.9M	148.7M	154.2M
Low	135.0M	137.1M	140.1M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	13.6%	13.6%
Avg	-	4.8%	3.7%
Low	-	-3.4%	-5.8%

EPS Forecast

EPS	2024	2025	2026
High	0.02	0.11	0.07
Avg	-	0.08	0.07
Low	-0.02	0.04	0.07

EPS Growth

EPS Growth	2024	2025	2026
High	-90.7%	-	-6.0%
Avg	-	-	-8.7%
Low	-	-	-12.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.